Advanced Research and Diagnostic Laboratory (ARDL)

A central biochemistry laboratory

The Advanced Research and Diagnostic Laboratory (ARDL) provides the latest technology and clinical laboratory testing services to researchers and other customers via a 16,000-square-foot customized facility. 

Constructed in 2013, the ARDL facility is recognized worldwide as a front-runner in innovative design and operational excellence.

High-Volume Immunoassay Testing Platforms

High-Volume Immunoassay Testing Platforms

  • Specimen collection / processing
  • Specimen testing and analysis
  • Quality control / assurance
  • Specimen storage

Mass Spectrometer Center

MS Center

  • Sample analysis
  • Quantitative proteomics
  • Assay development
  • Assay validation



  • Long-term sample storage
  • Cell cryopreservation
  • DNA sample storage
  • Power back-up protection


ARDL is fully accredited as a highly complex laboratory by the Clinical Laboratory Improvement Act (CLIA), the College of American Pathologists (CAP), and the New York State Department of Health.  High standards such as these are considered a starting point for ARDL, and a basis for a level of quality unsurpassed in the industry.


ARDL news

Steffes receives new contract

The NIH awarded new funding of $649,666 (first year) to PI Mike Steffes as part of the Epidemiology of Diabetes Intervention and Complications grant (EDIC).    Amy Karger and Amy Saenger are co-investigators on the grant which will be performed at ARDL.  The grant is expected to run through April 30, 2022.

Karger elected to national office

Effective January 1, 2018 Amy Karger will begin a 6-year term on the Board of Directors for the American Board of Clinical Chemistry. As a board member, she will help oversee the certification of laboratory directors for high complexity testing in clinical laboratories, and will serve on the clinical chemistry board examination sub-committee. 

Saenger is invited speaker and panelist

Amy Saenger was an invited speaker at the American Heart Association Scientific Sessions in Anaheim, CA recently.  Her presentation was on “Laboratory challenges to implementing high-sensitivity troponin assays.”  She was also an invited expert panelist at the FDA open meeting and workshop on Cardiac Troponin.  She spoke on behalf of the CAP regarding current lab utilization of cardiac troponin assays. 

ARDL Quality Report (through 6/30/2017) and the recent ARDL Customer Satisfaction Survey 

Highlights from the Quality Report:

  • Over 308,000 test results were reported on 41 different studies or projects.
  • Nearly 350,000 sample vials from 11 different studies were inventoried and placed in the biorepository.
  • New equipment included an Advance Osmometer 3320, Qiagen QiaSymphony, Hamilton Easy Blood liquid Handler and ELLA ELISA multiplexing platform..

Highlights from the Customer Satisfaction Survey:

  • 105 responses from 20 different studies
  • 78% of respondents would strongly recommend our laboratory services
  • 89% of respondents are extremely satisfied with their overall experience